15 January 2015
6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias.
An interesting poster presented during the 2014 ERS Congress features the importance of the six minute walk test with Spiropalm 6MWT in patients affected by fibrotic idiopathic interstitial pneumonias.
Aim of the present study was to assess 6MWT performance with the Spiropalm device (that allows a combined evaluation of lung function parameters and pulse-oxymetry) in a group of patients affected by clinically stable idiopathic pulmonary fibrosis (n=15) and fibrotic non specific interstitial pneumonia (n=8).
The study results show that "Spiropalm may be successfully applied to ameliorate 6MWT performance in fibrotic idiopathic interstitial pneumonias".
The poster details are the following:
- Title: "6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias"
- Authors: Marialuisa Bocchino, Raffaele Cobuccio, Marina De Martino, Gaetano Rea, Alessandro Matarese, Angelo Canora, Carolina Vitale, Anna Agnese Stanziola and Alessandro Sanduzzi - Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy
- Published in: ERJ September 1, 2014 vol. 44 no. Suppl 58 P3798
The abstract can be read at the following link: click here
Validation: Spiropalm #6MWT performance in patients with fibrotic interstitial #pneumonias http://t.co/DPdAjIecc0 pic.twitter.com/pXeMZzkFPw— COSMED (@cosmedhq) January 15, 2015